IQV — IQVIA HOLDINGS INC.

—
NYSE · Health Care · Life Sciences Tools & Services · CIK 1478242 ·
Last close
$257.60
Market Cap
$42.45B
52W High
$284.50
52W Low
$154.50
ADV30
1,392,626
Next earnings
2026-10-27

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 — — — — — — —
Jun 2026 4,368,000,000 1,435,000,000 569,000,000 256,000,000 29,881,000,000 1,909,000,000 23,580,000,000
Mar 2026 4,151,000,000 1,355,000,000 565,000,000 274,000,000 29,675,000,000 1,947,000,000 23,326,000,000
Dec 2025 4,364,000,000 1,436,000,000 651,000,000 514,000,000 29,944,000,000 — 23,314,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$2,736,000,000
Investing CF
$-2,240,000,000
Financing CF
$-34,000,000
CapEx
$-657,000,000
Dividends Paid
—
Buybacks
$-1,162,000,000
EPS Diluted TTM
$8.23
As of
2026-11-01

Balance + Analyst (yfinance extras)

Retained Earnings
$8,305,000,000
Inventory
—
Receivables
$3,332,000,000
ST Investments
$173,000,000
EBIT TTM
$2,337,000,000
Pretax Income TTM
$1,552,000,000
Interest Exp TTM
$785,000,000
Analysts
17

Yahoo Snapshot (yfinance, live)

Total Revenue
$17,311,000,576
EBITDA
$3,118,000,128
Free Cash Flow
$2,115,874,944
Enterprise Value
$58,078,982,144
Total Cash
$2,422,000,128
Total Debt
$16,314,000,384
Shares Out
164,800,000
Trailing EPS
$8.22
Book Value
$40.41
ROE
21.4%
ROA
5.1%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 16,310,000,000 2,287,000,000 1,360,000,000 29,944,000,000 23,314,000,000 6,503,000,000 2,654,000,000
Dec 2024 15,405,000,000 2,269,000,000 1,373,000,000 26,899,000,000 20,832,000,000 6,067,000,000 2,716,000,000
Dec 2023 14,984,000,000 2,061,000,000 1,358,000,000 26,681,000,000 20,569,000,000 6,112,000,000 2,149,000,000
Dec 2022 14,410,000,000 1,827,000,000 1,091,000,000 25,337,000,000 19,572,000,000 5,765,000,000 2,260,000,000

TTM Snapshot

Revenues TTM
$16,983,000,000
NetIncome TTM
$1,375,000,000
OpCashFlow TTM
—
Assets (Latest)
$29,881,000,000
Forward EPS
$14.22

Max Pain — expiry 2027-01-15

max pain strike: $240.00 · spot: $257.84 · call oi: 2,123 · put oi: 1,520
Expected Move to 2027-01-15: ±$32.90 (12.76%) — implied range $224.94 – $290.74 · ATM straddle on $260.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
IDXX IDEXX LABORATORIES INC /DE $54.38B $690.24 —
INCY INCYTE CORP $24.27B $119.09 —
MEDP Medpace Holdings, Inc. $18.27B $653.09 —
CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. $15.92B $332.16 —
ICLR ICON PLC $15.05B $195.02 —

News headlines (Yahoo Finance, 1h cache)

What iShares A.I. Innovation ETF (BAI) Bought: CoreWeave Leads on Nov. 16
2026-11-18 11:04 · Yahoo
ETFs Are Net Sellers of IQVIA (IQV) on Nov. 13
2026-11-17 11:03 · Yahoo
IQVIA Stock Jumps 59% in 6 Months: Here's What You Should Know
2026-11-13 14:12 · Yahoo
iShares A.I. Innovation (BAI) Buys $11.9 Million More IQVIA on Nov. 11
2026-11-13 11:04 · Yahoo
IQVIA: 3 Key Takeaways for Long-Term Investors
2026-11-10 01:52 · Yahoo
IQV Q3 deep dive: AI adoption and clinical momentum drive growth, guidance raised
2026-10-30 21:31 · Yahoo
5 revealing analyst questions from IQVIA’s Q3 earnings call
2026-10-30 21:15 · Yahoo
IQVIA (IQV) Q3 Earnings Beat Meets Valuation And Debt Questions
2026-10-28 08:09 · Yahoo
What IQVIA (IQV) Said on Its Q3 Earnings Call
2026-10-27 20:04 · Yahoo
IQVIA (IQV) Q3 2026 Earnings Call Transcript
2026-10-27 18:14 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.